Antidepressants in Spine Surgery: A Systematic Review to Determine Benefits and Risks
- Author:
Ahmed B BAYOUMI
1
;
Oyku IKIZGUL
;
Ceren Nur KARAALI
;
Selma BOZKURT
;
Deniz KONYA
;
Zafer Orkun TOKTAS
Author Information
- Publication Type:Review
- Keywords: Spine surgery; Clinical outcomes; Antidepressive agents; Systematic review
- MeSH: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Blood Platelets; Bone Density; Bupropion; Case-Control Studies; Cohort Studies; Delirium; Depression; Duloxetine Hydrochloride; Hemorrhage; Humans; Length of Stay; Methods; Neuralgia; Nociceptive Pain; Pain, Postoperative; Patient Satisfaction; Quality of Life; Risk Assessment; Serotonin; Spinal Cord; Spinal Cord Injuries; Spine; Surgeons; Venlafaxine Hydrochloride
- From:Asian Spine Journal 2019;13(6):1036-1046
- CountryRepublic of Korea
- Language:English
- Abstract: Antidepressant drugs can be advantageous in treating psychiatric and non-psychiatric illnesses, including spinal disorders. However, spine surgeons remain unfamiliar with the advantages and disadvantages of the use of antidepressant drugs as a part of the medical management of diseases of the spine. Our review article describes a systematic method using the PubMed/Medline database with a specific set of keywords to identify such benefits and drawbacks based on 17 original relevant articles published between January 2000 and February 2018; this provides the community of spine surgeons with available cumulative evidence contained within two tables illustrating both observational (10 studies; three cross-sectional, three case-control, and four cohort studies) and interventional (seven randomized clinical trials) studies. While tricyclic antidepressants (e.g., amitriptyline) and duloxetine can be effective in the treatment of neuropathic pain caused by root compression, venlafaxine may be more appropriate for patients with spinal cord injury presenting with depression and/or nociceptive pain. Despite the potential associated consequences of a prolonged hospital stay, higher cost, and controversial reports regarding the lowering of bone mineral density in the elderly, antidepressants may improve patient satisfaction and quality of life following surgery, and reduce postoperative pain and risk of delirium. The preoperative treatment of preexisting psychiatric diseases, such as anxiety and depression, can improve outcomes for patients with spinal cord injury-related disabilities; however, a preoperative platelet function assay is advocated prior to major spine surgical procedures to protect against significant intraoperative blood loss, as serotonergic antidepressants (e.g., selective serotonin reuptake inhibitors) and bupropion can increase the likelihood of bleeding intraoperatively due to drug-induced platelet dysfunction. This comprehensive review of this evolving topic can assist spine surgeons in better understanding the benefits and risks of antidepressant drugs to optimize outcomes and avoid potential hazards in a spine surgical setting.
